Prot #STU00222446: PROstate Vanguard Investigation: Stockholm3 for Enhanced Sensitivity and Targeted Assessment (PRO-VISTA) Clinical Utility Pilot

Project: Research project

Project Details

StatusActive
Effective start/end date11/4/24 → 11/4/27

Funding

  • A3P Biomedical AB (publ) (Prot #STU00222446)